Detalhe da pesquisa
1.
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Metabolism
; 58(10): 1503-16, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608207